INFO:

The FDA is now evaluating reports that patients who took the drug Paxlovid to treat Covid-19 may experience a second round of symptoms after recovering from the virus. Infectious disease experts claim viral rebound is not cause for alarm, but there are growing concerns for better guidance about how patients should respond.